Meeder Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.64M | Sell |
6,504
-792
| -11% | -$321K | 0.14% | 117 |
|
|
2025
Q1 | $3.63M | Buy |
7,296
+212
| +3% | +$105K | 0.22% | 73 |
|
|
2024
Q4 | $3.69M | Sell |
7,084
-181
| -2% | -$94.2K | 0.23% | 67 |
|
|
2024
Q3 | $4.49M | Sell |
7,265
-145
| -2% | -$89.7K | 0.29% | 54 |
|
|
2024
Q2 | $4.1M | Buy |
7,410
+2,005
| +37% | +$1.11M | 0.29% | 52 |
|
|
2024
Q1 | $3.14M | Buy |
5,405
+386
| +8% | +$224K | 0.32% | 49 |
|
|
2023
Q4 | $2.66M | Sell |
5,019
-238
| -5% | -$126K | 0.31% | 54 |
|
|
2023
Q3 | $2.66M | Sell |
5,257
-633
| -11% | -$320K | 0.33% | 48 |
|
|
2023
Q2 | $3.07M | Sell |
5,890
-563
| -9% | -$294K | 0.33% | 48 |
|
|
2023
Q1 | $3.72M | Buy |
6,453
+390
| +6% | +$225K | 0.43% | 38 |
|
|
2022
Q4 | $3.34M | Buy |
+6,063
| New | +$3.34M | 0.42% | 42 |
|